PETTY MUNGALA MIYANDA | Lecturer II

Petty Mungala Miyanda

pmiyanda@mu.ac.zm

Career Profile

Career Profile: Pharmacist by profession, lecturer and researcher, with a speciality in pharmaceutics.

Research interests: Innovative drug delivery technologies, smart materials for drug delivery, nanotechnology and biotechnology, pharmaceutical technology, pharmaceutical regulatory affairs and Intellectual property rights, pharmaceutical marketing, pharmacovigilance, risk management and drug safety

Education Background

BSC Pharmacy (UNZA), Msc Pharmaceutics (INDIA)

Publications

  1. Miyanda Petty M*, Priyanka S, Surya Gautam. Ethosomes: A Potential Transdermal Drug Delivery System-In-Depth Review. Ijppr.Human, 2017; Vol. 11 (1): 14-45.

  2. Miyanda Petty M, Surya Gautam. Graphene Oxide: A Potential Drug Carrier for Cancer Therapy: Review Article. Research & Reviews: A Journal of Pharmaceutical Science. 2017; 8:21-31.

  3. IMTC 2018 –Conference proceedings- Role of anti-oxidants in skin anti-aging

  4. Miyanda, Petty M. 2019- Novel Corona Virus: Incubation, Clinical Presentation, diagnosis, treatment, and prognosis Research & Reviews: Journal of Medicine (RRJoM) Vol 10, No 2 (2020) - Review Article

  5. Formulation and characterization of Neomycin Sulfate Loaded Ethosomes for Transdermal Delivery MP Miyanda SP Gautam.Journal of Pharmaceutics and Drug Research (ISSN:2640 6152) 2021: 4 (1), 462-469.

  6. PM Miyanda. Role of Physiotherapy in Respiratory Rehabilitation and Managing COVID-19 Patients in All Stages of the Disease Journal of Preventive and Rehabilitative Medicine 2022:4 (1), 21-26.

  7. MIYANDA PETTY.M Silver Nanoparticles for Enhancement of Antibiotic Antimicrobial Therapy.Vol 8, No 1 (2022)

  8. PM Miyanda, B Siame, AC Chisulo .Antibiotic prescribing patterns at a level one hospital using national treatment guidelines prescribing indicators in Zambia Journal of Preventive and Rehabilitative Medicine 2022: 4 (1), 59-64

  9. P Miyanda, S Gautam .Lipid Nanoparticle Technology a Key Component of COVID-19 mRNA Vaccines Journal of Preventive and Rehabilitative Medicine .2022:4 (1), 14-20.

  10. Miyanda Petty, Eric Sikaone Prevalence of Adverse Drug Reactions and Risk Factors Associated with first Line Anti- Tuberculosis Drugs . Research & Reviews: A Journal of Microbiology and Virology Vol 12, No 2 (2022).

  11. Miyanda Petty, Arifa Patel .Knowledge, Practice and Attitudes Towards Lifestyle Modifications Regarding Hypertension in Women. OmniScience: A Multi-disciplinary Journal. (2022).Volume 12, Issue 2. ISSN: 2231-0398.

  12. Miyanda Petty, Managing Chronic Kidney Disease using Plant Based Therapies indepth review. Research & Reviews A Journal of Pharmacognosy Vol 10, No 2 (2023).ISSN: 2394-7276

  13. Petty Miyanda, Dalitso Zgambo. Challenges and Opportunities in the African Pharmaceutical Industry. Research & Reviews: A Journal of Pharmaceutical Science. 2024; 15(03):-. Available from: https://journals.stmjournals.com/rrjops/article=2024/view=0 .

  14. Hanzooma Hatwiko, Royce Muchanga, Mwelwa Chembensofu, Martin Chakulya, Petty Miyanda, Patson Sichamba. Anthelminthic Activity of the Aqueous Extracts of Moringa oleifera Leaf Against Taenia solium Cysticerci, bioRxiv 2025.02.26.640305; doi: https://doi.org/10.1101/2025.02.26.640305